Contact
Please use this form to send email to PR contact of this press release:
Human medicines European public assessment report (EPAR): Lacosamide UCB, lacosamide, Epilepsies, Partial, Date of authorisation: 26/08/2019, Revision: 6, Status: Authorised
TO: